Ignite UK Launch Targets Red-Hot European CBD Market


Tony Deyes

August 1st, 2019

App, Exclusive, News, Top News


In June of 2019, the Centre for Medicinal Cannabis produced Britain’s most comprehensive study to date on the UK’s CBD sector, one of Europe’s largest, and found that the market is worth at least three times more than previously estimated, with 1.3 million regular users already spending over 300 million pounds annually on CBD products. That number is expected to be just shy of a billion pounds annually ($1.2billion USD) by 2025, equivalent to the entire UK herbal supplement category at present.

The study also found that the industry is officially considered mainstream in the UK, despite cannabis being illegal, largely as a result of steadily-growing awareness of CBD and its health & wellness applications. 6 million people, roughly 11% of the population, have already used CBD products, and that number is expected to continue its steady rise.

Click here to see the company corporate presentation

The European market, buoyed by a population twice the size of the US and Canada combined, has also surpassed all earlier market estimates, and is now expected to surpass $115 billion USD during this same period.

Ignite UK Launches in Style

With these lucrative emerging markets in mind, Ignite International Brands Ltd. (CSE: BILZ) organized a high-profile event at the famous Mandrake Hotel in central London, and an enormous presence at the inaugural Europe CBD Expo in London, to announce the launch of Ignite UK. This launch will serve as the hub of the company’s expansion into Europe’s emerging market, and its innovative “Ignited Kingdom” marketing campaign, where strategically-placed digital screens and billboards will extol the balanced, aspirational lifestyle Ignite encourages through CBD use.

Ignite is renowned for its use of engaging, intriguing marketing content, from its Unapologetic company Blog, to its Twitch TV channel, and backed up by the over 43 million-strong social media following of company founder and Chairman, Dan Bilzerian.

Ignite was a Gold sponsor of the Europe CBD Expo, and as a result, President of Ignite International Brands, Jim McCormick opened the event with a keynote speech in which he referred to the UK and European CBD markets as a “wide open space” that the company is well-placed to excel in. McCormick noted that Bilzerian’s social media presence has allowed the company to raise its brand profile despite the severe restrictions on advertising in the CBD space.

UK Launch a Precursor to European Expansion

Ignite UK is the beginning of the company’s European expansion, which introduces a line of lifestyle-based CBD products including tinctures, vapes, and topical, which are 100% natural and dosed to provide calming, lucid, and recharging effects. Five tincture and three vape flavours are currently available in the UK marketplace, with additional SKUs scheduled for release in the near future. New to the Ignite product line is a CBD lip balm, designed to serve as a reasonably-priced entry point for UK consumers curious about the Ignite brand and/or CBD topicals. Ignite UK sources the purest full-spectrum distillate and 99% pure CBD isolate and infuses them with fractionated coconut oil, natural flavour extracts, and terpenes, all of which are formulated to provide the holistic benefits of CBD.

Click here to see the company corporate presentation

The European CBD market is still in its infancy compared to US and Canadian markets, and though there have been a number of campaigns targeting the market, none have been on a significant scale, nor has a dominant brand yet to emerge. Ignite UK intends to capitalize on this opportunity with its first mover advantage and already-massive social media reach. Through the integration of traditional and digital out-of-home marketing, combined with social influencer campaigns, Ignite aims to become the most recognizable CBD brand in the world.

McCormick added, “North American CBD companies are increasing their presence in the UK and Europe to gain entry into a market that is anticipated to reach £16.5 billion in the next decade. We are excited to have launched our Ignite CBD product line in Europe. The initial response has been tremendous, and we look forward to diversifying our business across the UK and EU member states with our trade partners in the UK.”

European consumers can now purchase Ignite CBD Drops, Rechargeable Vape Pens, Disposable Vape Pens, and Lip Balms at two London retail locations as well as online at https://uk.ignitecbd.co/.

Ignite intends to expand its branding, marketing, licensing, sales and distribution business, across the United States, Canada, and international jurisdictions like Europe, and leverage multiple product platforms through branding, product development, targeted marketing and strategic supply chain partnerships in each of the target jurisdictions.

Click here to see the company corporate presentation

CEO and Chairman Dan Bilzerian, perhaps best known as one of the world’s most successful professional poker players, winning over $50 million in a single year, says “I’ve never half-assed anything I cared about. Everything I do, I do on the highest level and Ignite is going to top everything I’ve done before. I’ll spare no expense, cut no corners, and do whatever needs to be done in order to build Ignite into a world-renowned cannabis brand.”

For more information and updates, keep watching this page, or visit www.igniteinternational.co.

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Tony Deyes



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading